Application of Bevacizumab in Non-small Cell Lung Cancer
At present, non-small cell lung cancer is one of the highest incidence of cancers in the world, and its incidence increased year by year, this situation prompted people to continue to seek a variety of treatment in order to extend the survival of patients and improve the quality of life of patients....
Main Authors: | Ping XU, Hongmei LI |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2017-04-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2017.04.08 |
Similar Items
-
Evaluation of Efficacy and Safety of Bevacizumab Combined with Chemotherapy
for Chinese Patients with Advanced Non-small Cell Lung Cancer
by: Xiao ZHAO, et al.
Published: (2012-01-01) -
Long-term Survival of A Patient with Advanced Non-small Cell Lung Cancer
on Bevacizumab Therapy: Case Report and Review of the Literature
by: Wei WU, et al.
Published: (2013-06-01) -
Progress of Bevacizumab in the Front-line Treatment of Advanced Non-small Cell Lung Cancer
by: Bin AI, et al.
Published: (2020-07-01) -
Progress of Bevacizumab in Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
by: Yujie LIU, et al.
Published: (2019-02-01) -
Bevacizumab Combined with Chemotherapy for Advanced Non-small Cell Lung Cancer: A meta-analysis
by: Tao ZHANG, et al.
Published: (2013-02-01)